- Home
- BKV vs ATRC Comparison
BKV vs ATRC Comparison
Compare BKV & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKV
- ATRC
- Stock Information
- Founded
- BKV 2015
- ATRC 2000
- Country
- BKV United States
- ATRC United States
- Employees
- BKV N/A
- ATRC N/A
- Industry
- BKV Oil & Gas Production
- ATRC Medical/Dental Instruments
- Sector
- BKV Energy
- ATRC Health Care
- Exchange
- BKV Nasdaq
- ATRC Nasdaq
- Market Cap
- BKV 1.8B
- ATRC 1.6B
- IPO Year
- BKV 2024
- ATRC 2005
- Fundamental
- Price
- BKV $22.79
- ATRC $37.66
- Analyst Decision
- BKV Strong Buy
- ATRC Strong Buy
- Analyst Count
- BKV 9
- ATRC 10
- Target Price
- BKV $28.11
- ATRC $49.60
- AVG Volume (30 Days)
- BKV 352.5K
- ATRC 716.5K
- Earning Date
- BKV 08-12-2025
- ATRC 07-29-2025
- Dividend Yield
- BKV N/A
- ATRC N/A
- EPS Growth
- BKV N/A
- ATRC N/A
- EPS
- BKV N/A
- ATRC N/A
- Revenue
- BKV $756,795,000.00
- ATRC $499,946,000.00
- Revenue This Year
- BKV $49.49
- ATRC $14.63
- Revenue Next Year
- BKV $11.90
- ATRC $12.62
- P/E Ratio
- BKV N/A
- ATRC N/A
- Revenue Growth
- BKV 13.79
- ATRC 16.28
- 52 Week Low
- BKV $15.00
- ATRC $23.97
- 52 Week High
- BKV $26.78
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- BKV 64.23
- ATRC 64.88
- Support Level
- BKV $21.09
- ATRC $34.91
- Resistance Level
- BKV $21.61
- ATRC $36.20
- Average True Range (ATR)
- BKV 0.65
- ATRC 1.15
- MACD
- BKV 0.29
- ATRC 0.03
- Stochastic Oscillator
- BKV 95.00
- ATRC 95.16
About BKV BKV Corporation Common Stock
BKV Corp is a growth-driven energy company. Its core business is production of natural gas from its owned and operated upstream businesses. It operates in four business lines: natural gas production, natural gas gathering, processing and transportation (natural gas midstream business), power generation and carbon capture, utilization, and sequestration (CCUS).
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.